Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The ARH adaptor protein regulates endocytosis of the ROMK potassium secretory channel in mouse kidney
Liang Fang, Rita Garuti, Bo-Young Kim, James B. Wade, Paul A. Welling
Liang Fang, Rita Garuti, Bo-Young Kim, James B. Wade, Paul A. Welling
View: Text | PDF
Research Article Nephrology

The ARH adaptor protein regulates endocytosis of the ROMK potassium secretory channel in mouse kidney

  • Text
  • PDF
Abstract

Renal outer medullary potassium (ROMK) channels are exquisitely regulated to adjust renal potassium excretion and maintain potassium balance. Clathrin-dependent endocytosis plays a critical role, limiting urinary potassium loss in potassium deficiency. In renal disease, aberrant ROMK endocytosis may contribute to potassium retention and hyperkalemia. Previous work has indicated that ROMK endocytosis is stimulated by with-no-lysine (WNK) kinases, but the endocytotic signal and the internalization machinery have not been defined. Here, we found that ROMK bound directly to the clathrin adaptor molecule autosomal recessive hypercholesterolemia (ARH), and this interaction was mediated by what we believe to be a novel variant of the canonical “NPXY” endocytotic signal, YxNPxFV. ARH recruits ROMK to clathrin-coated pits for constitutive and WNK1-stimuated endocytosis, and ARH knockdown decreased basal rates of ROMK endocytosis, in a heterologous expression system, COS-7 cells. We found that ARH was predominantly expressed in the distal nephron where it coimmunoprecipitated and colocalized with ROMK. In mice, the abundance of kidney ARH protein was modulated by dietary potassium and inversely correlated with changes in ROMK. Furthermore, ARH-knockout mice exhibited an altered ROMK response to potassium intake. These data suggest that ARH marks ROMK for clathrin-dependent endocytosis, in concert with the demands of potassium homeostasis.

Authors

Liang Fang, Rita Garuti, Bo-Young Kim, James B. Wade, Paul A. Welling

×

Figure 6

ROMK sequence requirements of ARH-dependent internalization match the requirements of ARH binding.

Options: View larger image (or click on image) Download as PowerPoint
ROMK sequence requirements of ARH-dependent internalization match the re...
(A) Mapping the sequence of the endocytotic signal. Point mutations each residue of the putative trafficking signal (YDN375PNFVL) were created in the N2.1/ROMK channel and cell surface expression was measured by HA antibody binding and cell surface luminescence (RLU) in the absence (white bars) and presence of ARH (black bars). Comparison of individual constructs in the absence and presence of ARH showed that cell surface expression in the presence of ARH was significantly smaller than in absence of ARH (* P < 0.001). Comparison of the mutants versus WT channel showed that the mutants had significantly greater cell surface expression than WT channel (#P < 0.05; n = 3). Total cellular input of channel protein was not influenced by ARH (data not shown). (B) Endocytosis of ROMK (WT ROMK and indicated mutants) was measured with the biotinylation internalization assay (5 minute time point) in COS-7 cells expressing exogenous ARH. Y373A, N375A, P376A, F378A, and V379A mutants attenuated endocytosis. n = 3; *P < 0.001. (C) Representative GST-ROMK/His-ARH interaction assay with WT ROMK and indicated mutants. (D) Quantification of ARH interaction of GST, WT GST-ROMK-C, and mutant GST-ROMK-C. n = 3; *P < 0.01.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts